IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,510.00
Bid: 2,500.00
Ask: 2,510.00
Change: 40.00 (1.62%)
Spread: 10.00 (0.40%)
Open: 2,460.00
High: 2,530.00
Low: 2,460.00
Prev. Close: 2,470.00
OXIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

13 Feb 2014 07:00

RNS Number : 9397Z
Oxford Instruments PLC
13 February 2014
 



Release date: 13 February 2014

 

Oxford Instruments plc

Interim Management Statement

 

 

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, today issues its Interim Management Statement which covers the period from 1 October 2013 to date.

The positive trend seen in the second quarter of the year has continued with orders ahead of the prior year in the four months since September. Year to date, order run rate is ahead of last year in Asia, Europe and North America.

Year to date sales remain behind the same period last year. However we are anticipating a strong February and March and, despite the recent strength of Sterling and continuing underperformance at our Omicron facility in Germany, we are expecting performance for the year to be broadly in-line with the prior year.

On 22 January 2014 the Group announced that it had received acceptances from approximately 95% of the shareholders of Andor plc and that the offer was wholly unconditional from that date. Andor is a UK based high-technology company specialising in the manufacture of high-end scientific cameras, microscope systems and analytical software for the materials and life science industries. Andor's technology will extend our capability into the optical domain, which is the primary technology used for analysing biological samples at the nano scale, consistent with our recently announced strategy to expand into Nano-Bio.

The £175 million acquisition of Andor was funded from existing cash resources, a new £100 million revolving facility and a £60 million term facility. Both debt facilities are from a banking club comprising HSBC, Santander and RBS.

On 12 November 2013 the Group announced the acquisition of RMG Technology (RMG), completed on 8 November 2013. RMG is a young UK technology company which brings a unique laser technology to our Industrial Analysis business. Progress with integrating the business is on plan and we are seeing considerable interest from our Industrial Analysis customers.

On 21 December 2013, the Group acquired Roentgenanalytik Systeme, a small company based near Frankfurt, Germany, supplying X-ray analysis instrumentation to industrial markets. The acquisition will broaden Industrial Analysis' product range and give Roentgenanalytik access to global markets and increase investment in product development.

Save as described in this statement, there has been no significant change in the financial position of the Group in the period.

 

- Ends -

 

Enquiries:

 

 

Oxford Instruments plc Tel: 01865 393200

Jonathan Flint, Chief Executive

Kevin Boyd, Group Finance Director

 

MHP Tel: 020 3128 8100

Rachel Hirst / Rory King

 

Issued for and on behalf of Oxford Instruments plc

 

 

 

Notes to Editors  

 

About Oxford Instruments plc

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion. 

The first technology business to be spun out from Oxford University, Oxford Instruments is now a global company with over 2300 staff worldwide and is listed on the FTSE250 index of the London Stock Exchange (OXIG).  Its objective is to be the leading provider of new generation tools and systems for the research and industrial sectors with a focus on nanotechnology. Its key market sectors include nano-fabrication and nano-materials. The company's strategy is to expand the business into the life sciences arena, where nanotechnology and biotechnology intersect

This involves the combination of core technologies in areas such as low temperature, high magnetic field and ultra high vacuum environments; Nuclear Magnetic Resonance; x-ray, electron, laser and optical based metrology; atomic force microscopy; optical imaging; advanced growth, deposition and etching.

Oxford Instruments aims to pursue responsible development and deeper understanding of our world through science and technology. Its products, expertise, and ideas address global issues such as energy, environment, security and health.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBUGDDRXBBGSD
Date   Source Headline
2nd Jul 20242:11 pmPRNBlocklisting - Interim Review
1st Jul 202412:21 pmPRNTotal Voting Rights
1st Jul 20249:14 amRNSCompletion of acquisition of FemtoTools AG
25th Jun 202412:51 pmPRNHolding(s) in Company
25th Jun 202410:40 amPRNPublication of Annual Report 2024 and Notice of Annual General Meeting 2024
11th Jun 202411:18 amPRNDirector/PDMR Shareholding
11th Jun 20247:01 amRNSOxford Instruments plc to acquire FemtoTools AG
11th Jun 20247:00 amRNSPreliminary Results
6th Jun 20241:05 pmPRNHolding(s) in Company
5th Jun 20248:24 amPRNDirectorate Change
3rd Jun 20241:35 pmPRNHolding(s) in Company
3rd Jun 20248:22 amPRNTotal Voting Rights
31st May 20248:50 amPRNHolding(s) in Company
13th May 20241:15 pmPRNDirector/PDMR Shareholding
1st May 202410:12 amRNSTotal Voting Rights
24th Apr 20244:31 pmPRNHolding(s) in Company
24th Apr 20244:29 pmPRNHolding(s) in Company
16th Apr 20247:00 amRNSTrading Update
11th Apr 202412:54 pmPRNDirector/PDMR Shareholding
2nd Apr 202410:32 amPRNTotal Voting Rights
20th Mar 20244:26 pmPRNDirector/PDMR Shareholding
12th Mar 20248:30 amPRNDirector/PDMR Shareholding
1st Mar 20248:00 amPRNTotal Voting Rights
28th Feb 202411:25 amPRNHolding(s) in Company
12th Feb 20244:15 pmPRNDirector/PDMR Shareholding
1st Feb 20249:10 amPRNTotal Voting Rights
19th Jan 202411:30 amPRNHolding(s) in Company
11th Jan 20244:25 pmPRNDirector/PDMR Shareholding
10th Jan 20247:00 amRNSAcquisition of First Light Imaging SAS
2nd Jan 20241:31 pmPRNBlocklisting - Interim Review
2nd Jan 20241:19 pmPRNTotal Voting Rights
12th Dec 20239:00 amPRNDirector/PDMR Shareholding
1st Dec 20239:00 amPRNTotal Voting Rights
22nd Nov 20232:01 pmPRNAppointment of Independent Non-Executive Director
15th Nov 20234:42 pmPRNDirector/PDMR Shareholding
15th Nov 202312:29 pmPRNDirector/PDMR Shareholding
14th Nov 20237:00 amRNSHalf-Year Results
13th Nov 20231:37 pmPRNDirector/PDMR Shareholding
1st Nov 20239:00 amPRNTotal Voting Rights
17th Oct 20234:13 pmPRNHolding(s) in Company
12th Oct 20234:03 pmPRNDirector/PDMR Shareholding
12th Oct 20237:00 amRNSHalf Year Trading Update
11th Oct 20239:32 amPRNDirector/PDMR Shareholding
2nd Oct 20238:53 amPRNTotal Voting Rights
27th Sep 20234:19 pmPRNDirector/PDMR Shareholding
25th Sep 20234:20 pmPRNDirector/PDMR Shareholding
19th Sep 20231:41 pmPRNAnnual General Meeting 2023 Results
14th Sep 20237:00 amPRNBlock Listing Application
12th Sep 20233:27 pmPRNDirector/PDMR Shareholding
10th Aug 20232:16 pmPRNDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.